The Latest Breaking News from Vaccine

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

BioNTech SE (NASDAQ:BNTX) reported a third-quarter per-share loss of 14 cents (12 cents in euros) on Monday, a turnaround from earnings of 81 cents reported a year ago, missing the consensus earnings of 75 cents per share.

Benzinga · Nov 3, 2025

Voices: ‘It’s like the NHS would rather pay a hospital bill over a cheap jab’: Readers react to Covid vaccine cuts

YOUR VIEWS: Our community has criticised the government’s decision to restrict free Covid boosters, describing it as unfair, confusing, and short-sighted, and urged a review of eligibility to protect vulnerable people still at risk

The Independent UK · Nov 3, 2025

Strict school vaccine mandates work, and parents don’t game the system − new research

When four states between 2015 and 2021 stopped allowing parents to opt their children out of receiving routine vaccines without a medical reason, vaccination rates among kindergartners increased substantially. That’s the key finding from our new study published in the medical journal JAMA Pediatrics.

The Conversation · Nov 3, 2025

GSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026

British pharmaceutical giant GSK Plc (NYSE:GSK) on Wednesday reported upbeat third-quarter results and upgraded its full-year 2025 guidance.

Benzinga · Oct 29, 2025

Future pandemics are a 'certainty' — and we must be better prepared to distribute vaccines equitably, says Dr. Seth Berkley

Months before COVID-19 was declared a pandemic, efforts were already underway to ensure low-income countries would get access to future vaccines against the infection. The book "Fair Doses" tells that story and discusses the ongoing fight for vaccine equity around the world.

LiveScience · Oct 28, 2025

'This is a completely different level of anti-vaccine engagement than we've ever seen before,' says epidemiologist Dr. Seth Berkley

Epidemiologist Dr. Seth Berkley spoke to Live Science about the importance of vaccine equity and the obstacles undermining it, as well as the political challenges to vaccines being raised in the U.S.

LiveScience · Oct 28, 2025

CSL shares plunge to six-year low as growth stalls

CSL shares have tumbled more than 15 per cent to their lowest level since 2018 after it cut its profit forecast given falling US flu vaccine rates.

AAP · Oct 28, 2025

‘Complete insanity’: Trump once again declares war on Tylenol, and the internet’s collective headache is back

Lack of a medical degree has never been a problem for Donald Trump in giving out medical advice against Tylenol. So, the nation’s self-appointed doctor is at it again, diagnosing from his golf cart and prescribing from his imagination.

The Mary Sue · Oct 27, 2025

Mpox warning issued in UK after cases spread in Europe

A new UKHSA report said 16 cases of the ‘clade Ib’ mpox strain have been reported in England

The Independent UK · Oct 27, 2025

Threat to US vaccines as CDC staff supporting key advisory panel laid off

Critics say scientists ‘held hostage’ by RFK Jr as changes mean vaccine development and guidance in peril

The Guardian - US · Oct 27, 2025